Document Type : Research Paper
Authors
Abstract
The aim of the Present study was to investigate the effect of resistance training on muscle strength in patients with prostate cancer. Twenty-four non-metastatic prostate cancer patients voluntarily participated in the study and randomly assigned into two group of 12; an experimental (mean ±SD, age73 ± 6.1 year, height 172.5 ± 5.2 cm, weight 75.4±8.6 kg) and control groups (mean ±SD, age72 ± 5.3 year, height 171.1 ± 8.3 cm, weight 75.5±6.8 kg). The experimental group performed resistance training for 10 weeks but the control group did not participate in any regular exercise. Before and after resistance exercise, muscle strength of biceps brachial, triceps, quadriceps and hamstring were measured using a hand dynamometer. In addition to this testosterone hormone also was evaluated. Independent and dependent t-test was used for analyzing the data. Significance was set on P
Keywords
Main Subjects
1. Poorkiani M, Hazrati M, Abbaszadeh A, Jafari P, Sadeghi M, Dejbakhsh T, et al. Does a rehabilitation program improve quality of life in breast cancer patients? Payesh. 2010, 9(1): 61-8.
2. Sajadian A, Kaviani A, Montazeri A, Haji Mahmodi M, Ebrahimi M, Samie F, et al. The use of complementary and alternative therapies in cancer patients. Payesh. 2004, 4(3): 197-205.
3. MardaniHamule M, ShahrakiVahed A. Relationship between mental health and quality of life in cancer patients. JSSU. 2010; 18 (2) :111-7.
4. Yavari P, Mehrabi U, Pour-Hoseingholi M A. Knowledge and practice of women toward breast self-examination: A case-control study. J Ardabil Univ Med Sci. 2005; (4) : 371-7.
5. Sharafi A, Khoshgard K, Nikoofar A. Measurement of the absorbed dose by Bladder and Rectum in the radiation therapy of Prostate cancer by Yhermoluminescent Dosimetry Method. RJMS. 2009; 16 (64): 7-13.
6. Clay C, Perera S, Wagner J M, Miller M E, Nelson, Greenspan S L. Physical function in men with prostate cancer on androgen deprivation therapy. Physical Therapy. 2007; 87(10): 1325-33.
7. Parkin D M, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin. 2005; 55(2): 74-108
8. Newton R U, Taaffe D R, Spry N, Gardiner R A, Levin G, Wall B, et al. Phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer. BMC Cancer. 2009; 9: 210.
9. Mohammadi Falah M R, Jafari S, Alizade M, Mokhtari M R. The effect of intravesical BCG therapy on serum PSA level. Urmia Medical Journal. 2008, 2(19): 152-7.
10. Morgentaler A. Testosterone, Prostate cancer: What are the risks for middle-aged men? UrolClin North Am. 2011; 38(2): 119-24.
11.American Urological Association (AUA). Prostate-specific antigen (PSA) best practice policy. Oncology (Williston Park). 2000; 14: 267–72.
12. Goldenberg S L, Koupparis A, Robinson M E. Differing levels of testosterone and the prostate: A physiological interplay. Nat Rev Urol. 2011; 31(7): 365-77
13. Smith M R, Finkelstein J S, McGovern F J, Zietman A L, Fallon M A, Schoenfeld D A, et al. Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab. 2002; 87(2): 599-603.
14.Greenspan S L, Coates P, Sereika S M, Nelson J B, Trump D L, Resnick N M. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J Clin Endocrinol Metab. 2005; 90(12): 6410-7.
15. Galva˜o D A, Newton R U. Review of exercise intervention studies in cancer patients. J Clin Oncol. 2005; 23(4): 899-909.
16. Sharifi N, Gulley J L, Dahut W L. Androgen deprivation therapy for prostate cancer. JAMA. 2005; 294: 238–44.
17. Segal R J, Reid R D, Courneya K S, Malone S C, Parliament M B, Scott C G, et al. Resistance exercise in men receiving androgen deprivation therapy for Prostate cancer. J Clin Oncol. 2003; 21(9):1653-9.
18. Galvão D A, Nosaka K, Taaffe D R, Spry N, Kristjanson L J, McGuigan M R, et al. Resistance training and reduction of treatment side effects in prostate cancer patients. Med Sci Sports Exerc. 2006; 38(12): 2045-52.
19. Culos Reed S N, Robinson J L, Lau H, O’Connor K, Keats M R. Benefits of a physical activity intervention for men with prostate cancer. J Sport Exerc Psychol. 2007; 29(1): 118-27.
20. Galvao D A, Taaffe D R, Spry N, Joseph D, Newton R U. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for Prostate cancer without bone metastases: A randomized controlled trial. J Clin Oncol. 2010; 28(2): 340-7.
21. Hansen P A, Dechet C B, Porucznik C A, LaStayo P C. Comparing eccentric resistance exercise in prostate cancer survivors on and off hormone therapy: A pilot study. PMR. 2009; 1(11): 1019-24.
22. Sale D G. Neural adaptation to resistance training. Med Sci Sports Exerc. 1988; 20(5 Suppl): 135-45.
23. Saylor P J, Smith M R. Metabolic complications of androgen deprivation therapy for Prostate cancer. J Urol. 2009; 181(5): 1998-2006. Discussion; 2007-2008.
24. Galvao D A, Nosaka K, Taaffe D R, Peake J, Spry N, Suzuki K, et al. Endocrine and immune responses to resistance training in prostate cancer patients. Prostate Cancer Prostatic Dis. 2008; 11(2): 160-5.
25. Galvão D A, Spry N A, Taaffe D R, Newton R U, Stanley J, Shannon T, et al. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer. BJU Int. 2008; 102(1): 44-7.
26. Galvao D A, Taaffe D R, Spry N, Newton R U. Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer. Prostate Cancer Prostatic Dis. 2007; 10(4): 340-6.
27. Disibio G, French S W. Metastatic patterns of cancer: Results from a large autopsy study. Arch Pathol Lab Med. 2008; 132(6): 931-9.
28. Hakkinen K, Pakarinen A, Kraemer W J, Newton R U, Alen M. Basal concentrations and acute responses of serum hormones and strength development during heavy resistance training in middle-aged and elderly men and women. J Gerontol A Biol Sci Med Sci. 2000; 55(2): 95-105.
)